• Orgenesis to Acquire Koglio Therapeutics contractpharma
    October 09, 2020
    Will accelerate the commercialization of Koligo’s KYSLECEL, a personalized islet cell therapy available in the U.S. for chronic and recurrent acute pancreatitis.
PharmaSources Customer Service